Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.420
+0.050 (1.48%)
Jun 30, 2026, 4:00 PM EDT - Market closed
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $373.44 million as of June 30, 2026. Its market cap has increased by 18.29% in one year.
Market Cap
373.44M
Enterprise Value
253.83M
1-Year Change
18.29%
Ranking
Category
Stock Price
$3.42
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $373.44M, an increase of 291.86%. That is a compound annual growth rate of 12.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 373.40M | -1.71% |
| Dec 31, 2025 | 379.90M | -66.84% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
| Feb 18, 2015 | 95.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DiaMedica Therapeutics | 389.04M |
| Compass Therapeutics | 388.99M |
| Palisade Bio | 387.08M |
| Fennec Pharmaceuticals | 383.15M |
| Lexeo Therapeutics | 377.69M |
| Upstream Bio | 377.13M |
| OmniAb | 372.58M |
| Vanda Pharmaceuticals | 369.23M |